Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity. [electronic resource]
Producer: 20070801Description: 1285-97 p. digitalISSN:- 0340-7004
- Adenocarcinoma -- immunology
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Breast Neoplasms -- immunology
- Burkitt Lymphoma -- immunology
- Carcinoma -- immunology
- Cell Line, Tumor -- drug effects
- Cisplatin -- pharmacology
- Colorectal Neoplasms -- immunology
- Concanavalin A -- pharmacology
- Cytotoxicity, Immunologic -- drug effects
- Diphosphonates -- pharmacology
- Doxorubicin -- pharmacology
- Drug Screening Assays, Antitumor
- Drug Synergism
- Etoposide -- pharmacology
- Female
- Genes, T-Cell Receptor delta
- Genes, T-Cell Receptor gamma
- Humans
- Imidazoles -- pharmacology
- Interferon-gamma -- biosynthesis
- Lovastatin -- analogs & derivatives
- Lung Neoplasms -- immunology
- Male
- Membrane Glycoproteins -- analysis
- Neoplasms -- immunology
- Perforin
- Pore Forming Cytotoxic Proteins -- analysis
- Prostatic Neoplasms -- immunology
- Receptors, Antigen, T-Cell, gamma-delta -- immunology
- T-Lymphocyte Subsets -- immunology
- Urinary Bladder Neoplasms -- immunology
- Vincristine -- pharmacology
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.